| Literature DB >> 35854095 |
I-Wen Chen1, Cheuk-Kwan Sun2,3, Kuo-Chuan Hung4,5, Chong-Chi Chiu6,7,8, Chih-Wei Hsu9, Chien-Ming Lin4, Shu-Wei Liao4, I-Chia Teng4.
Abstract
This meta-analysis aimed at exploring the impact of opioid-free anesthesia (OFA) on pain score and opioid consumption in patients undergoing bariatric surgery (BS). Literature search identified eight eligible trials. Forest plot revealed a significantly lower pain score (mean difference (MD) = - 0.96, p = 0.0002; 318 patients), but not morphine consumption (MD = - 5.85 mg, p = 0.1; 318 patients) at postoperative 24 h in patients with OFA than in those without. Pooled analysis also showed a lower pain score (p = 0.002), morphine consumption (p = 0.0003) in the postanesthetic care unit, and risk of postoperative nausea/vomiting (p = 0.0003) in the OFA group compared to the controls. In conclusion, this meta-analysis demonstrated that opioid-free anesthesia improved pain outcomes immediately and at 24 h after surgery without a beneficial impact on opioid consumption at postoperative 24 h. KEY POINTS: • Roles of opioid-free anesthesia (OFA) in bariatric surgery (BS) were investigated. • Outcomes included postoperative pain score, opioid use, and nausea/vomiting risk. • OFA was associated with lower 24-h pain score but not opioid consumption. • Lower pain score and opioid consumption were noted in the postanesthetic care unit. • OFA correlated with a lower risk of postoperative nausea/vomiting.Entities:
Keywords: Bariatric surgery; Dexmedetomidine; Nonopioid; Opioid-free; Quality of recovery
Mesh:
Substances:
Year: 2022 PMID: 35854095 DOI: 10.1007/s11695-022-06213-7
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 3.479